Tag: narrow therapeutic index
Bridging Studies for NTI Generics: Ensuring Safety and Efficacy
Explore the critical role of bridging studies in ensuring the safety and efficacy of Narrow Therapeutic Index (NTI) generic drugs. Learn about FDA guidelines, bioequivalence criteria, and the challenges manufacturers face.
Side Effects After Switching to Generics: When to Worry and What to Do
Discover when generic drug switches cause real side effects. Learn about narrow therapeutic index drugs, bioequivalence limits, and practical steps to manage medication changes safely.
Phenytoin and Generics: What You Need to Know About Therapeutic Drug Monitoring
Phenytoin has a narrow therapeutic range and unpredictable absorption, making generic switches risky. Learn when and how to monitor levels to avoid toxicity or breakthrough seizures.
Pharmacist Concerns About NTI Generics: What You Need to Know in 2025
Pharmacists are raising alarms about NTI generics-medications where tiny dose changes can cause serious harm. Learn why warfarin, levothyroxine, and phenytoin require extra caution, what’s being done, and how to stay safe in 2025.